Sabin Strains (Five-Dose) (2.5ml/vial) (hereinafter referred to as "msIPV") was prequalified by WHO
Sinovac Holding Group Co., Ltd.
Anti-Rabies Cocktail Monoclonal Antibody: Approved for emergency treatment in China. Developed by Synermore, with investment from SINOVAC.
EN
